Article
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression
20 Oct 2021
Abstract excerpt
BACKGROUND: Renal Cell Carcinoma (RCC) is difficult to treat with 5-year survival rate of 10% in metastatic patients. Main reasons of therapy failure are lack of validated biomarkers and scarce knowledge of the biological processes occurring during RCC progression. Thus, the investigation of mechanisms regulating RCC progression is fundamental to improve RCC therapy. METHODS: In order to identify molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
